---
title: "Vasodilators in clinical day to day practice"
authors:
  - name: Dr L Padma
    affiliation: "MBBS, MD DIP IN DIABETOLOGY PRACTICAL CARDIOLOGY AND GEDIATRIC CARE"
---

Vasodilators are latest drugs which are useful in the management of hypertension , angina, heart failure , MI and preeclampsia hypertensive emergencies etc.,

The different classes of vasodilators used in current clinical practice has different actions on the coronary arteries and peripheral vasculature on both arteries and veins . Vasodilators more commonly affect the arteries in the human body but some vasodilators such as nitro-glycerine can affect the venous system of the body predominantly.

<div style="overflow: scroll">

**Table 1: Vasodilators and uses.**

| | |Drugs |MOA |AE |CI |Uses |
|--- |--- |--- |--- |--- |--- |--- |
|Directly acting vasodilators|Venous|NITRATES (GTN AND NITROGLYCERIN)|RELEASES NO THROUGH CYCLIC GMP|TACCHYCARDIA,HEADACHE FLUSING AND ORTHOSTATIC HYPOTENSION|AS THEY DECREASE PRELOAD DO NOT USE IN INFERIOR MI OR RIGHT VENTRICULAR INFARCTION|ACUTE AND CHRONIC ANGINA|
||Arterial|CCB (DHP LIKE AMLODIPINE AND NON DHP LIKE VERAPAMIL)|BLOCKS CALCIUM CHANNELS IN THE CARDIAC AND SMOOTH MUSCLE|GINGIVAL HYPERPLASIA AND PERIPHERAL EDEMA ,AVBLOCK BRADYCARDIA AND CONSTIPATION|HYPOTENSION AND HYPERSENSITIVITY|HTN ARRYTHMIA ANGINA|
|||MINOXIDIL DIAZOXIDE|ATP sensitive Potassium channel openers|HYPERTRICHOSIS FLUID RETENTION||Alopecia|
|||PRAZOSIN|ALPHA BLOCKER|First dose hypotension|CHF|3rd line drug in HTN|
|||HYDRALAZINE|DIRECTLY RELAXES ARTERIOLAR SMOOTH MUSCLES THROUGH CYCLIC AMP|TACCHYCARDIA FLUID RETENTION AND SLE|CAD ANGINA RHD AS IT CAUSES COMPENSATORY TACCHYCARDIA|PIH|
||Mixed|ACE INHIBITORS ARB|PREVENT CONVERSION OF ANGIOTENSIN I TO II    PREVENTS ANGIOTENSINII FROM BINDING TO ITS RECEPTOR (CARDIORENO PROTECTIVE)|DRY COUGH HYPERKALEMIA AND HYPOTENSION HYPERKALEMIA AND HYPOTENSION|PREGNANCY AND HEREDITARY ANGIOEDEMA PREGNANCY|Heart failure HTN MI CCF SCLERODE RMA CRISIS|
|||SODIUM NITROPRUSSIDE|BOTH VENOUS AND ARTERIOLAR DILATOR RELEASING NO|CYANIDE TOXICITY||Hypertensive emergencies|
|BETA 2 RECEPTOR AGONIST||SALBUTAMOL TERBUTALINE|Beta 2 mediated vasodilatation|Tremors hypokalemia|||
|CENTRALLY ACTING ALPHA 2 RECEPTOR AGONIST||CLONIDINE METHYLDOPA|Acts on presynaptic alpha 2 receptor and decreases sympathetic outflow|Rebound hypertension on withdrawal||LAST DRUG OF CHOICE IN HTN FIRST DRUG OF CHOICE IN PIH BUT NOW A DAYS WE ARE INTO “NIFEDIPINE RETARDOR LABETELOL”|
|ENDOTHELIN RECEPTOR ANTAGONISTS||BOSENTAN AMBRISENTAN|ETA and ETB receptor blocker|Anaemia teratogenecity||Pulmonary arterial hypertension|
|BETA BLOCKERS WITH NITRIC OXIDE VASODILATATION||BISOPROLOL NEBIVOLOL| BETA 1 BLOCK REDUCES HEART RATE AND CARDIA WORK LOAD AND NO CAUSES VASODILATATION|BRADYCARDIA|Heart Block|YOUNG HYPERTENSIVES|

</div>

[View table in new window](/volume-5/issue-1/vasodilators-in-clinical-day-to-day-practice-table1/)

### CLINICAL PEARLS

1. Educate the patient about adverse effects
2. Importance of taking their vasodilator medication as prescribed
3. Under treatment or non compliance can cause severe hypertension and complications which
are preventable
4. Ask the patient to inform if they have missed or want to stop the treatment
5. Educate LSM , plant based eating habits 10,000 steps per day aerobic excercises and avoid
smoking and alcohol and recreational drugs
6. CLINICAL PHARMACOLOGIST should assist in selection, dosing, MEDICATION
RECONCILLIATION and patient education